If you’ve been researching ketamine therapy, one of the first questions that probably comes to mind is whether it’s actually right for you. It’s a fair question, and the answer isn’t the same for everyone.
Ketamine therapy isn’t a first-line treatment, and it isn’t appropriate for every person who walks through the door. But for the right candidate, it can represent a meaningful turning point after months or years of struggling with conditions that haven’t responded well to standard treatments.
At Rivendell Health, every patient considering ketamine therapy or Spravato goes through a thorough evaluation before any treatment begins. This post walks through the key factors that typically determine candidacy, so you can come to that conversation better prepared.
In medicine, being a “good candidate” for a treatment generally means two things: the treatment is likely to benefit you based on your diagnosis and history, and there are no medical or psychiatric factors that would make the treatment unsafe or inappropriate.
For ketamine therapy, this framing matters more than usual. Ketamine is a powerful medication with a specific mechanism of action. It works best when it’s part of a broader treatment plan, and it works best for people whose symptoms fit the profile the research supports. A provider who skips a proper evaluation isn’t doing you a favor.
That said, candidacy isn’t a rigid checklist. It’s a clinical judgment made by a qualified provider who understands your full history. The factors below are a starting point, not a final answer.
Ketamine therapy is primarily used for mental health conditions where traditional treatments have fallen short. At Rivendell Health, ketamine therapy is offered for individuals experiencing:
Treatment-Resistant Depression (TRD) This is the most established use case for ketamine. Treatment-resistant depression is typically defined as depression that has not adequately responded to at least two different antidepressant medications taken at the right dose for the right duration. Ketamine’s rapid-acting mechanism makes it a particularly relevant option when standard antidepressants have not delivered results.
Major Depressive Disorder (MDD) with Suicidal Ideation For patients experiencing major depressive disorder alongside active suicidal thoughts, Spravato (esketamine) carries an FDA approval specifically addressing this presentation. This is a context where speed of symptom relief is especially critical.
Post-Traumatic Stress Disorder (PTSD) Growing research supports the use of ketamine in PTSD treatment, particularly for individuals whose symptoms have not responded to first-line therapies. Given the Colorado Springs patient population, which includes a significant number of veterans and active military, this is a meaningful area of focus at Rivendell Health.
Severe Anxiety Disorders Ketamine therapy is not a standard treatment for anxiety on its own, but for individuals where severe anxiety co-occurs with depression or trauma-related conditions, it may be considered as part of a comprehensive plan.
Bipolar Depression Ketamine may be appropriate for the depressive phase of bipolar disorder in certain patients, though this requires careful psychiatric oversight given the complexity of the condition.
Obsessive-Compulsive Disorder (OCD) Some research supports ketamine’s potential role in OCD treatment. This would be evaluated case by case based on diagnosis, severity, and prior treatment history.
While a formal evaluation is the only way to know for certain, the following are common indicators that a patient may be a strong candidate for ketamine therapy:
You have tried multiple medications without adequate relief. If two or more antidepressants or other psychiatric medications have not produced meaningful improvement at appropriate doses, that history is one of the strongest signals that ketamine therapy may be worth exploring.
Your symptoms are persistent and significantly affecting your daily life. Ketamine therapy tends to be considered when depression, anxiety, or trauma symptoms are severe enough to interfere with work, relationships, sleep, or basic functioning, and those symptoms have not responded to conventional treatment.
You are already engaged in or open to psychiatric care. Ketamine therapy is not a standalone fix. Providers look for patients who are willing to participate in a broader treatment plan that includes psychiatric follow-up and, where appropriate, therapy.
You are medically stable. Ketamine raises blood pressure temporarily during treatment. Candidates are generally expected to have blood pressure and cardiovascular health within a range that a provider is comfortable monitoring during sessions.
You are not actively in crisis. Outpatient ketamine therapy is not designed for acute psychiatric emergencies. Candidates are typically stable enough to participate in scheduled outpatient treatment.
Candidacy is not all-or-nothing, but certain factors do require careful evaluation before proceeding. A provider may pause, adjust the treatment approach, or determine that another option is more appropriate if any of the following apply.
Uncontrolled high blood pressure. Because ketamine can temporarily elevate blood pressure, patients with hypertension that is not well-managed may need to address that first.
Active psychosis or a history of psychotic disorders. Schizophrenia and related conditions are generally considered contraindications for ketamine therapy due to the dissociative properties of the medication.
Active or recent substance use disorder. Ketamine has potential for misuse, and patients with an active substance use disorder require a more nuanced evaluation. This does not mean automatic disqualification, but it does mean the clinical picture needs to be assessed carefully.
Certain cardiovascular conditions. Patients with specific heart conditions may not be appropriate candidates. A provider will review your medical history as part of the intake process.
Pregnancy. Ketamine therapy is not recommended during pregnancy.
Some medications. Certain medications can interact with ketamine. Your prescribing provider will review your current medications as part of the evaluation to identify any concerns.
None of these factors are listed to discourage you from asking. They are listed because a thorough evaluation that accounts for all of them is exactly what protects patients and leads to better outcomes.
Yes, and it’s worth understanding the distinction because Rivendell Health offers both.
Spravato (esketamine) is a nasal spray form of ketamine with FDA approval for two specific indications: treatment-resistant depression and major depressive disorder with suicidal ideation. Because it carries FDA approval for these uses, most major insurance plans cover it, including many of the plans accepted at Rivendell Health. Spravato candidacy is tied closely to those two diagnoses and requires meeting criteria for treatment resistance.
Ketamine therapy (administered by injection at Rivendell Health) is used off-label for a broader range of conditions, including PTSD, severe anxiety, OCD, and bipolar depression. It is generally not covered by insurance, which is an important practical consideration. The candidacy criteria are less narrowly defined but still require a full psychiatric evaluation.
If you’re unsure which option might apply to you, the evaluation process will address that directly. Learn more about both options on our Spravato and Ketamine Therapy page.
If you reach out to Rivendell Health about ketamine therapy, the process starts with a comprehensive consultation rather than a treatment session. Here’s what that typically involves:
A thorough review of your mental health history. Your provider will want to understand your diagnosis, how long you’ve been experiencing symptoms, and what treatments you’ve tried, including medications, therapy, and any other interventions.
A review of your medical history. This covers current medications, cardiovascular health, blood pressure, and any other physical health factors relevant to safe treatment.
An honest conversation about your goals and expectations. Ketamine therapy works best when patients understand what it is and isn’t likely to do. Your provider will talk through realistic outcomes based on your specific situation.
A treatment recommendation, not a sales pitch. If ketamine therapy is not the right fit for you at this time, your provider will tell you that and discuss what other options may be more appropriate within Rivendell’s care model.
Because Rivendell Health uses a collaborative care model with both psychiatry and internal medicine under one roof, the evaluation process can account for your full health picture, not just your psychiatric history in isolation.
Coming into an evaluation prepared helps you make a better decision. Here are a few questions worth raising with your provider:
There are no wrong answers to these questions. A provider who fields them well is one you can trust with your care.
Ketamine therapy is not right for everyone, and the only way to know whether it’s right for you is to have a real conversation with a qualified provider who can evaluate your specific situation.
At Rivendell Health, that conversation starts with an appointment. Our psychiatric team will review your history, answer your questions, and give you an honest assessment of your options. Whether ketamine therapy turns out to be the right path or not, you’ll leave with a clearer picture of where to go next.
Rivendell Health gave me my life back. Highly recommend, everyone should see them.
Phone: (719) 726-6573
Fax: (719) 771-0460
Email: support@RivendellHealth.com
Location: 1465 Kelly Johnson Blvd. Ste 310
Colorado Springs, CO 80920